Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2018
Dec. 31, 2017
Current Assets:    
Cash and Cash Equivalents $ 21,304,407 $ 185,151
Accounts receivable and other receivables, net 207,122 227,918
Inventory, net 765,870 247,466
Current portion of operating lease right-of-use asset 95,866
Prepaid expenses and other current asset 866,219 108,352
Total Current Assets 23,239,484 768,887
Property and equipment, net 350,106 376,920
Operating lease right-of-use asset, non-current portion 183,746
Intangible assets, net 98,430 106,167
Deferred public offering costs 1,367,730
Other assets 64,673 67,309
Total Assets 23,936,439 2,687,013
Current Liabilities:    
Accounts payable 1,555,220 4,228,073
Accrued expenses 2,737,344 23,135,344
Accrued issuable equity 1,131,474 2,939,906
Derivative liabilities 24,240 3,448,390
Current portion of convertible notes payable 50,000
Convertible notes payable - related party 747,567
Notes payable 337,966 597,966
Current portion of operating lease liabilities 95,866
Current portion of deferred revenue 401,458 383,771
Total Current Liabilities 6,283,568 35,531,017
Convertible notes payable, non-current portion, net of debt discount of $0 and $499,435 as of September 30, 2018 and December 31, 2017, respectively 3,200,096
Operating lease liabilities, non-current portion 187,548
Deferred revenue, non-current portion 18,456 50,283
Total Liabilities 6,489,572 38,781,396
Series B Convertible Preferred Stock, 10,000 shares designated, 0 and 8,250 issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 825,000
Commitments and contingencies  
Stockholders' Equity (Deficiency):    
Common stock, $0.001 par value, 500,000,000 shares authorized, 25,564,103 and 5,523,673 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively 25,564 5,524
Additional paid-in capital 175,021,206 119,499,141
Accumulated deficit (157,599,908) (156,435,278)
Total Stockholders' Equity (Deficiency) 17,446,867 (36,919,383)
Total Liabilities and Stockholders' Equity (Deficiency) 23,936,439 2,687,013
Series A Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 11,000
Series C Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 230
Series D Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; $ 5